IBDEI2SS ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,44616,1,3,0)
;;=3^ADLS Training Ea 15Min
;;^UTILITY(U,$J,358.3,44617,0)
;;=96105^^166^2215^2^^^^1
;;^UTILITY(U,$J,358.3,44617,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44617,1,2,0)
;;=2^96105
;;^UTILITY(U,$J,358.3,44617,1,3,0)
;;=3^Aphasia Assessment w/ Interp & Rpt,Per Hr
;;^UTILITY(U,$J,358.3,44618,0)
;;=90901^^166^2215^7^^^^1
;;^UTILITY(U,$J,358.3,44618,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44618,1,2,0)
;;=2^90901
;;^UTILITY(U,$J,358.3,44618,1,3,0)
;;=3^Biofeedback Training Any Method
;;^UTILITY(U,$J,358.3,44619,0)
;;=97750^^166^2215^10^^^^1
;;^UTILITY(U,$J,358.3,44619,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44619,1,2,0)
;;=2^97750
;;^UTILITY(U,$J,358.3,44619,1,3,0)
;;=3^Extremity Performance Testing Ea 15Min
;;^UTILITY(U,$J,358.3,44620,0)
;;=97165^^166^2215^12^^^^1
;;^UTILITY(U,$J,358.3,44620,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44620,1,2,0)
;;=2^97165
;;^UTILITY(U,$J,358.3,44620,1,3,0)
;;=3^OT Evaluation,Low Complexity
;;^UTILITY(U,$J,358.3,44621,0)
;;=97166^^166^2215^13^^^^1
;;^UTILITY(U,$J,358.3,44621,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44621,1,2,0)
;;=2^97166
;;^UTILITY(U,$J,358.3,44621,1,3,0)
;;=3^OT Evaluation,Moderate Complexity
;;^UTILITY(U,$J,358.3,44622,0)
;;=97167^^166^2215^11^^^^1
;;^UTILITY(U,$J,358.3,44622,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44622,1,2,0)
;;=2^97167
;;^UTILITY(U,$J,358.3,44622,1,3,0)
;;=3^OT Evaluation,High Complexity
;;^UTILITY(U,$J,358.3,44623,0)
;;=97168^^166^2215^14^^^^1
;;^UTILITY(U,$J,358.3,44623,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44623,1,2,0)
;;=2^97168
;;^UTILITY(U,$J,358.3,44623,1,3,0)
;;=3^OT Re-Evaluation
;;^UTILITY(U,$J,358.3,44624,0)
;;=97161^^166^2215^16^^^^1
;;^UTILITY(U,$J,358.3,44624,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44624,1,2,0)
;;=2^97161
;;^UTILITY(U,$J,358.3,44624,1,3,0)
;;=3^PT Evaluation,Low Complexity
;;^UTILITY(U,$J,358.3,44625,0)
;;=97162^^166^2215^17^^^^1
;;^UTILITY(U,$J,358.3,44625,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44625,1,2,0)
;;=2^97162
;;^UTILITY(U,$J,358.3,44625,1,3,0)
;;=3^PT Evaluation,Moderate Complexity
;;^UTILITY(U,$J,358.3,44626,0)
;;=97163^^166^2215^15^^^^1
;;^UTILITY(U,$J,358.3,44626,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44626,1,2,0)
;;=2^97163
;;^UTILITY(U,$J,358.3,44626,1,3,0)
;;=3^PT Evaluation,High Complexity
;;^UTILITY(U,$J,358.3,44627,0)
;;=97164^^166^2215^18^^^^1
;;^UTILITY(U,$J,358.3,44627,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44627,1,2,0)
;;=2^97164
;;^UTILITY(U,$J,358.3,44627,1,3,0)
;;=3^PT Re-Evaluation
;;^UTILITY(U,$J,358.3,44628,0)
;;=96112^^166^2215^8^^^^1
;;^UTILITY(U,$J,358.3,44628,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44628,1,2,0)
;;=2^96112
;;^UTILITY(U,$J,358.3,44628,1,3,0)
;;=3^Developmental Testing w/ Int & Rpt,1st Hr
;;^UTILITY(U,$J,358.3,44629,0)
;;=96113^^166^2215^9^^^^1
;;^UTILITY(U,$J,358.3,44629,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44629,1,2,0)
;;=2^96113
;;^UTILITY(U,$J,358.3,44629,1,3,0)
;;=3^Developmental Testing w/ Int & Rpt,Ea Addl 30 min
;;^UTILITY(U,$J,358.3,44630,0)
;;=97172^^166^2215^6^^^^1
;;^UTILITY(U,$J,358.3,44630,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,44630,1,2,0)
;;=2^97172
;;^UTILITY(U,$J,358.3,44630,1,3,0)
;;=3^Athletic Trn Re-Eval Plan,Ea 20 min
;;^UTILITY(U,$J,358.3,44631,0)
;;=97171^^166^2215^3^^^^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2SS 3780 printed Dec 13, 2024@02:35:07 Page 2
IBDEI2SS ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,44616,1,3,0)
+2 ;;=3^ADLS Training Ea 15Min
+3 ;;^UTILITY(U,$J,358.3,44617,0)
+4 ;;=96105^^166^2215^2^^^^1
+5 ;;^UTILITY(U,$J,358.3,44617,1,0)
+6 ;;=^358.31IA^3^2
+7 ;;^UTILITY(U,$J,358.3,44617,1,2,0)
+8 ;;=2^96105
+9 ;;^UTILITY(U,$J,358.3,44617,1,3,0)
+10 ;;=3^Aphasia Assessment w/ Interp & Rpt,Per Hr
+11 ;;^UTILITY(U,$J,358.3,44618,0)
+12 ;;=90901^^166^2215^7^^^^1
+13 ;;^UTILITY(U,$J,358.3,44618,1,0)
+14 ;;=^358.31IA^3^2
+15 ;;^UTILITY(U,$J,358.3,44618,1,2,0)
+16 ;;=2^90901
+17 ;;^UTILITY(U,$J,358.3,44618,1,3,0)
+18 ;;=3^Biofeedback Training Any Method
+19 ;;^UTILITY(U,$J,358.3,44619,0)
+20 ;;=97750^^166^2215^10^^^^1
+21 ;;^UTILITY(U,$J,358.3,44619,1,0)
+22 ;;=^358.31IA^3^2
+23 ;;^UTILITY(U,$J,358.3,44619,1,2,0)
+24 ;;=2^97750
+25 ;;^UTILITY(U,$J,358.3,44619,1,3,0)
+26 ;;=3^Extremity Performance Testing Ea 15Min
+27 ;;^UTILITY(U,$J,358.3,44620,0)
+28 ;;=97165^^166^2215^12^^^^1
+29 ;;^UTILITY(U,$J,358.3,44620,1,0)
+30 ;;=^358.31IA^3^2
+31 ;;^UTILITY(U,$J,358.3,44620,1,2,0)
+32 ;;=2^97165
+33 ;;^UTILITY(U,$J,358.3,44620,1,3,0)
+34 ;;=3^OT Evaluation,Low Complexity
+35 ;;^UTILITY(U,$J,358.3,44621,0)
+36 ;;=97166^^166^2215^13^^^^1
+37 ;;^UTILITY(U,$J,358.3,44621,1,0)
+38 ;;=^358.31IA^3^2
+39 ;;^UTILITY(U,$J,358.3,44621,1,2,0)
+40 ;;=2^97166
+41 ;;^UTILITY(U,$J,358.3,44621,1,3,0)
+42 ;;=3^OT Evaluation,Moderate Complexity
+43 ;;^UTILITY(U,$J,358.3,44622,0)
+44 ;;=97167^^166^2215^11^^^^1
+45 ;;^UTILITY(U,$J,358.3,44622,1,0)
+46 ;;=^358.31IA^3^2
+47 ;;^UTILITY(U,$J,358.3,44622,1,2,0)
+48 ;;=2^97167
+49 ;;^UTILITY(U,$J,358.3,44622,1,3,0)
+50 ;;=3^OT Evaluation,High Complexity
+51 ;;^UTILITY(U,$J,358.3,44623,0)
+52 ;;=97168^^166^2215^14^^^^1
+53 ;;^UTILITY(U,$J,358.3,44623,1,0)
+54 ;;=^358.31IA^3^2
+55 ;;^UTILITY(U,$J,358.3,44623,1,2,0)
+56 ;;=2^97168
+57 ;;^UTILITY(U,$J,358.3,44623,1,3,0)
+58 ;;=3^OT Re-Evaluation
+59 ;;^UTILITY(U,$J,358.3,44624,0)
+60 ;;=97161^^166^2215^16^^^^1
+61 ;;^UTILITY(U,$J,358.3,44624,1,0)
+62 ;;=^358.31IA^3^2
+63 ;;^UTILITY(U,$J,358.3,44624,1,2,0)
+64 ;;=2^97161
+65 ;;^UTILITY(U,$J,358.3,44624,1,3,0)
+66 ;;=3^PT Evaluation,Low Complexity
+67 ;;^UTILITY(U,$J,358.3,44625,0)
+68 ;;=97162^^166^2215^17^^^^1
+69 ;;^UTILITY(U,$J,358.3,44625,1,0)
+70 ;;=^358.31IA^3^2
+71 ;;^UTILITY(U,$J,358.3,44625,1,2,0)
+72 ;;=2^97162
+73 ;;^UTILITY(U,$J,358.3,44625,1,3,0)
+74 ;;=3^PT Evaluation,Moderate Complexity
+75 ;;^UTILITY(U,$J,358.3,44626,0)
+76 ;;=97163^^166^2215^15^^^^1
+77 ;;^UTILITY(U,$J,358.3,44626,1,0)
+78 ;;=^358.31IA^3^2
+79 ;;^UTILITY(U,$J,358.3,44626,1,2,0)
+80 ;;=2^97163
+81 ;;^UTILITY(U,$J,358.3,44626,1,3,0)
+82 ;;=3^PT Evaluation,High Complexity
+83 ;;^UTILITY(U,$J,358.3,44627,0)
+84 ;;=97164^^166^2215^18^^^^1
+85 ;;^UTILITY(U,$J,358.3,44627,1,0)
+86 ;;=^358.31IA^3^2
+87 ;;^UTILITY(U,$J,358.3,44627,1,2,0)
+88 ;;=2^97164
+89 ;;^UTILITY(U,$J,358.3,44627,1,3,0)
+90 ;;=3^PT Re-Evaluation
+91 ;;^UTILITY(U,$J,358.3,44628,0)
+92 ;;=96112^^166^2215^8^^^^1
+93 ;;^UTILITY(U,$J,358.3,44628,1,0)
+94 ;;=^358.31IA^3^2
+95 ;;^UTILITY(U,$J,358.3,44628,1,2,0)
+96 ;;=2^96112
+97 ;;^UTILITY(U,$J,358.3,44628,1,3,0)
+98 ;;=3^Developmental Testing w/ Int & Rpt,1st Hr
+99 ;;^UTILITY(U,$J,358.3,44629,0)
+100 ;;=96113^^166^2215^9^^^^1
+101 ;;^UTILITY(U,$J,358.3,44629,1,0)
+102 ;;=^358.31IA^3^2
+103 ;;^UTILITY(U,$J,358.3,44629,1,2,0)
+104 ;;=2^96113
+105 ;;^UTILITY(U,$J,358.3,44629,1,3,0)
+106 ;;=3^Developmental Testing w/ Int & Rpt,Ea Addl 30 min
+107 ;;^UTILITY(U,$J,358.3,44630,0)
+108 ;;=97172^^166^2215^6^^^^1
+109 ;;^UTILITY(U,$J,358.3,44630,1,0)
+110 ;;=^358.31IA^3^2
+111 ;;^UTILITY(U,$J,358.3,44630,1,2,0)
+112 ;;=2^97172
+113 ;;^UTILITY(U,$J,358.3,44630,1,3,0)
+114 ;;=3^Athletic Trn Re-Eval Plan,Ea 20 min
+115 ;;^UTILITY(U,$J,358.3,44631,0)
+116 ;;=97171^^166^2215^3^^^^1
